Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Cytokines

Recombinant Human CCL14/NCC-2 Protein, N-GST

Catalog #:   YHH32301 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q16627
Protein length: Thr20-Asn93
Overview

Catalog No.

YHH32301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Thr20-Asn93

Predicted molecular weight

35.51 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q16627

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

HCC-1/HCC-3, CCL14, Small-inducible cytokine A14, Chemokine CC-1/CC-3, C-C motif chemokine 14, SCYA14, NCC-2, HCC-1(1-74), NCC2

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CCL14 / NCC-2
References

Potential diagnostic marker gene set for non-alcoholic steatohepatitis associated hepatocellular carcinoma with lymphocyte infiltration., PMID:40386252

Spatial transcriptional landscape of human heart failure., PMID:40335066

Proteomic and Demographic Comparisons of Recurrent Ischemic Stroke Patients., PMID:40268817

Low RYR2 Level Relates to Poor Prognosis of Patients With Lung Adenocarcinoma by Promoting Tumor Cell Proliferation and Inhibiting Immune Cell Infiltration., PMID:40200715

Advances in the diagnosis of early biomarkers for acute kidney injury: a literature review., PMID:40045274

Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes., PMID:39915484

Molecular Subtype Identification and Potential Drug Prediction Based on Anoikis-Related Genes Expression in Keratoconus., PMID:39898909

Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study., PMID:39751938

Performance of urinary C-C motif chemokine ligand 14 and the renal resistive index in predicting persistent AKI., PMID:39676224

C-C motif chemokine ligand 14 characterization for prediction of persistent severe AKI in post-cardiac surgery children., PMID:39557702

Dendritic cell-derived lncRNAs in patients with acute coronary syndrome., PMID:39433980

Cytokine and chemokine receptor profiles in adipose tissue vasculature unravel endothelial cell responses in HIV., PMID:39263801

A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers., PMID:39211038

Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer., PMID:39129286

Persistent acute kidney injury biomarkers: A systematic review and meta-analysis., PMID:39127297

The chemokine CCL14 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma., PMID:39030403

Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis., PMID:38887558

Silencing immune-infiltrating biomarker CCDC80 inhibits malignant characterization and tumor formation in gastric cancer., PMID:38872096

Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma., PMID:38750318

Revealing prognostic insights of programmed cell death (PCD)-associated genes in advanced non-small cell lung cancer., PMID:38728242

Predictive performance of two types of urinary biomarkers for renal non-recovery in sepsis-associated acute kidney injury: a prospective observational study., PMID:38702662

CCL14 testing to guide clinical practice in patients with AKI: Results from an international expert panel., PMID:38678981

Assessing the role of Chemokine (C-C motif) ligand 14 in AKI: a European consensus meeting., PMID:38666354

Aqueous Macrophages Contribute to Conserved CCL2 and CXCL10 Gradients in Uveitis., PMID:38650614

Sepsis-Associated Acute Kidney Injury: Where Are We Now?, PMID:38541160

Prognostic Biomarkers and AKI: Potential to Enhance the Identification of Post-Operative Patients at Risk of Loss of Renal Function., PMID:38476861

Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts., PMID:38003685

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data., PMID:37965447

Serum proteomics identifies S100A11 and MMP9 as novel biomarkers for predicting the early efficacy of sublingual immunotherapy in allergic rhinitis., PMID:37647677

Alterations in ileal transcriptomics during an intestinal barrier challenge in lactating Holstein cows fed a Saccharomyces cerevisiae fermentation product identify potential regulatory processes., PMID:37616596

Performance of urinary C-C motif chemokine ligand 14 for the prediction of persistent acute kidney injury: a systematic review and meta-analysis., PMID:37596698

Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma., PMID:37545521

mRNA expression of immune factors by milk somatic cells from healthy Holstein lactating cows., PMID:37397638

ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity., PMID:37215979

Comprehensive Explorations of CCL28 in Lung Adenocarcinoma Immunotherapy and Experimental Validation., PMID:37006812

Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients., PMID:36988335

Analysis of urinary C-C motif chemokine ligand 14 (CCL14) and first-generation urinary biomarkers for predicting renal recovery from acute kidney injury: a prospective exploratory study., PMID:36941674

RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma., PMID:36817422

Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma., PMID:36409028

CCL14 exacerbates intraplaque vulnerability by promoting neovascularization in the human carotid plaque., PMID:35973397

Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury., PMID:35919538

Towards a Better Crystal Ball: Urinary C-C Motif Chemokine Ligand 14 (CCL14) and Persistent Severe AKI., PMID:35919534

Bioinformatic Analysis of Prognostic Value of SNTG2 with Immune Implications in Lung Adenocarcinoma., PMID:35637702

Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis., PMID:35585016

Genome-Wide Identification of Associations of Circulating Molecules With Spontaneous Coronary Artery Dissection and Aortic Aneurysm and Dissection., PMID:35571188

Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment., PMID:34938730

Identification of early diagnostic biomarkers via WGCNA in gastric cancer., PMID:34864309

Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma., PMID:34612781

C-C motif chemokine ligand 14 inhibited colon cancer cell proliferation and invasion through suppressing M2 polarization of tumor-associated macrophages., PMID:34096611

External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury., PMID:34059102

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CCL14/NCC-2 Protein, N-GST [YHH32301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only